Bendavia 50mg

DRUG2 trials

Sponsors

Stealth BioTherapeutics Inc.

Conditions

HealthyHealthy Volunteers

Phase 1

A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)

CompletedNCT01754818

Stealth BioTherapeutics Inc.Healthy

Start: 2012-11-30End: 2013-02-28Updated: 2013-02-06

Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days

CompletedNCT01786915

Stealth BioTherapeutics Inc.Healthy Volunteers

Start: 2013-02-28End: 2013-03-31Updated: 2014-04-02